Singapore- and NYC-based Holmusk, which offers real-world clinical data and analytics for the behavioral health industry, raised a $45M Series B led by Veradigm
Rachel Chitra / DealStreetAsia :
Context & Ripple Effects
Behavioral health has been drawing venture money across every layer of the stack: Intellect raised $10M to extend its employer-side mental health benefits, Grow Therapy pulled in a $75M Series B for provider practice tools, and the space's earlier wave included Quartet Health's $40M Series B back in 2016. What nearly all of that funding built was care delivery or access.
Holmusk sits on a different layer: real-world clinical data and analytics for behavioral health, and the fact that Veradigm — a health IT operator, not a typical growth fund — led the $45M Series B signals that incumbents want proprietary evidence assets attached to their platforms.
First-order effects
- Holmusk gets the capital to scale its behavioral health data assets, while Veradigm secures a preferred relationship with the evidence layer its own products increasingly need.
- Care-delivery rivals like Grow Therapy and Quartet Health now compete against a funded player whose product is proof of outcomes rather than another channel of care.
Second-order effects
- Payers and employers buying from delivery-side vendors can start demanding measured results, forcing providers of virtual practices and benefit programs to buy or partner for analytics they don't have in-house.
- Veradigm's lead position pressures other health IT platforms to either acquire or invest in real-world data capabilities rather than license them at arm's length.
Third-order effects
- If the pattern holds, behavioral health splits into a delivery tier and an evidence tier, with reimbursement and enterprise contracts increasingly gated on real-world outcome data that only a few funded specialists control.
- A strategic-led round like this points toward consolidation where data infrastructure becomes the acquisition target for health IT roll-ups, not just another SaaS category.
The trend: Venture and strategic capital in behavioral health is shifting from funding new channels of care to funding the data and evidence infrastructure that decides which care gets paid for.